ibusal - søkeresultat

fingolimod teva 0.5 mg

teva gmbh - fingolimodhydroklorid - kapsel, hard - 0.5 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

tyruko

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Norge - norsk - Statens legemiddelverk

fingolimod tillomed 0.5 mg

tillomed pharma gmbh - schönefeld - fingolimodhydroklorid - kapsel, hard - 0.5 mg

Norge - norsk - Statens legemiddelverk

xultophy 100 e/ ml / 3.6 mg/ ml

orifarm as - insulin degludek / liraglutid - injeksjonsvæske, oppløsning i ferdigfylt penn - 100 e/ ml / 3.6 mg/ ml

Norge - norsk - Statens legemiddelverk

xultophy 100 e/ ml / 3.6 mg/ ml

2care4 aps - insulin degludek / liraglutid - injeksjonsvæske, oppløsning i ferdigfylt penn - 100 e/ ml / 3.6 mg/ ml

Norge - norsk - Statens legemiddelverk

xyzal 5 mg

ucb nordic as - levocetirizindihydroklorid - tablett, filmdrasjert - 5 mg